Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.

Wu, Jinhui; Song, Chenchen; Jiang, Chenxiao; Shen, Xin; Qiao, Qian; Hu, Yiqiao

Wu, Jinhui; Song, Chenchen; Jiang, Chenxiao; Shen, Xin; Qiao, Qian; Hu, Yiqiao.

Affiliation

Wu J; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China.

Mol Pharm ; 10(10): 3555-63, 2013 Oct 07.

Article in En | MEDLINE | ID: mdl-23679916

Subject(s)

Antineoplastic Agents/metabolism; Nanoparticles/chemistry; Phosphoproteins/metabolism; RNA-Binding Proteins/metabolism; 3T3 Cells; Animals; Antineoplastic Agents/pharmacology; Cell Line; Cell Membrane/metabolism; Cell Survival/drug effects; Endostatins/pharmacology; Humans; MCF-7 Cells; Mice; Paclitaxel/metabolism; Paclitaxel/pharmacology; Phosphoproteins/antagonists & inhibitors; RNA-Binding Proteins/antagonists & inhibitors; Nucleolin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphoproteins / RNA-Binding Proteins / Nanoparticles / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2013 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google